Tumor–stroma ratio in the primary tumor is a prognostic factor in early breast cancer patients, especially in triple-negative carcinoma patients

Author： Kruijf Esther  

Publisher： Springer Publishing Company

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.125, Iss.3, 2011-02, pp. : 687-696

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Primary tumor classification according to methylation pattern is prognostic in patients with early stage ER-negative breast cancer

By Hoesel Anneke  

Breast Cancer Research and Treatment, Vol. 131, Iss. 3, 2012-02 ,pp. : 859-869

Springer Publishing Company

Access to resources Recommend Favorite

Increased serum tumor necrosis factor receptor-associated factor-6 expression in patients with non-metastatic triple-negative breast cancer

By              

Oncology Letters, Vol. 9, Iss. 6, 2015-01 ,pp. : 2819-2824

Spandidos Publications

Access to resources Recommend Favorite

Pathological tumor response to neoadjuvant chemotherapy using anthracycline and taxanes in patients with triple-negative breast cancer

By                

Experimental and Therapeutic Medicine, Vol. 2, Iss. 2, 2011-01 ,pp. : 257-264

Spandidos Publications

Access to resources Recommend Favorite

Pro-metastatic tumor–stroma interactions in breast cancer

By Gangadhara Sharath   Barrett-Lee Peter   Nicholson Robert I   Hiscox Stephen  

Future Oncology, Vol. 8, Iss. 11, 2012-11 ,pp. : 1427-1442

Future Medicine

Access to resources Recommend Favorite

Expression and prognostic value of estrogen receptor β in patients with triple-negative and triple-positive breast cancer

By            

Experimental and Therapeutic Medicine, Vol. 9, Iss. 6, 2015-01 ,pp. : 2147-2150

Spandidos Publications

Access to resources Recommend Favorite